Приказ основних података о документу

dc.creatorHaroun, Michelyne
dc.creatorTratrat, Christophe
dc.creatorKositsi, Katerina
dc.creatorTsolaki, Evangelia
dc.creatorPetrou, Anthi
dc.creatorAldhubiab, Bandar
dc.creatorAttimarad, Mahesh
dc.creatorHarsha, Sree
dc.creatorGeronikaki, Athina
dc.creatorVenugopala, Katharigatta N.
dc.creatorElsewedy, Heba S.
dc.creatorSoković, Marina
dc.creatorGlamočlija, Jasmina
dc.creatorĆirić, Ana
dc.date.accessioned2018-05-31T09:39:41Z
dc.date.available2900-01-01
dc.date.issued2018
dc.identifier.urihttp://www.eurekaselect.com/159582/article
dc.identifier.urihttps://radar.ibiss.bg.ac.rs/handle/123456789/3071
dc.description.abstractBACKGROUND Thiazole and benzothiazole derivatives, as well as thiazolidinones are very important scaffolds in medicinal chemistry. Literature has revealed that they possess a wide spectrum of biological activities including antimicrobial activity. OBJECTIVE The goal of this paper is the designing of new benzothiazole based thiazolidinones and the evaluation of their biological activities. METHODS The designed compounds were synthesized using classical organic synthesis methods. The antimicrobial activity was evaluated using the method of microdilution. RESULTS The twelve newly synthesized compounds showed antimicrobial properties. All compounds appeared to be more active than ampicillin in most studied strains and in some cases, more active than streptomycin. Antifungal activity, in most cases was also better than the reference drugs ketoconazole and bifonazole. The prediction of cytotoxicity revealed that the synthesized compounds were not toxic (LD50 350-1000 mg/kg of body weight). Docking studies on the antibacterial activity confirmed the biological results. CONCLUSION The twelve new compounds were synthesized and studied for their antimicrobial activity. The compounds appeared to be promising antimicrobial agents and could be the lead compounds for new, more potent drugs. According to the docking prediction, the compounds could be MurB inhibitors.en
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173032/RS//
dc.relationDeanship of Scientific Research of King Faisal University (Grant number 150237)
dc.rightsrestrictedAccess
dc.sourceCurrent Topics in Medicinal Chemistry
dc.subjectAntibacterial
dc.subjectAntifungal
dc.subjectBenzothiazole
dc.subjectDrugs.
dc.subjectMicrodilution
dc.subjectThiazolidinone
dc.titleNew Benzothiazole-based Thiazolidinones as Potent Antimicrobial Agents. Design, synthesis and Biological Evaluation.en
dc.typearticleen
dc.rights.licenseARR
dcterms.abstractТсолаки, Евангелиа; Елсеwедy, Хеба С.; Соковић, Марина; Гламочлија, Јасмина; Героникаки, Aтхина; Ћирић, Aна; Хароун, Мицхелyне; Тратрат, Цхристопхе; Коситси, Катерина; Петроу, Aнтхи; Aлдхубиаб, Бандар; Aттимарад, Махесх; Харсха, Срее; Венугопала, Катхаригатта Н.;
dc.rights.holder© Bentham Science Publishers
dc.citation.issue1
dc.citation.volume18
dc.identifier.doi10.2174/1568026618666180206101814
dc.identifier.pmid29412109
dc.identifier.scopus2-s2.0-85046985967
dc.identifier.wos000427993100006
dc.citation.apaHaroun, M., Tratrat, C., Kositsi, K., Tsolaki, E., Petrou, A., Aldhubiab, B., … Ciric, A. (2018). New Benzothiazole-based Thiazolidinones as Potent Antimicrobial Agents. Design, synthesis and Biological Evaluation. Current Topics in Medicinal Chemistry, 18(1), 75–87.
dc.citation.vancouverHaroun M, Tratrat C, Kositsi K, Tsolaki E, Petrou A, Aldhubiab B, Attimarad M, Harsha S, Geronikaki A, Venugopala KN, Elsewedy HS, Sokovic M, Glamoclija J, Ciric A. New Benzothiazole-based Thiazolidinones as Potent Antimicrobial Agents. Design, synthesis and Biological Evaluation. Curr Top Med Chem. 2018;18(1):75–87.
dc.citation.spage75
dc.citation.epage87
dc.type.versionpublishedVersionen
dc.citation.rankM22


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу